Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

FREMANOR, INC.

NPI: 1306922737 · VEGA ALTA, PR 00692 · Clinical Medical Laboratory · NPI assigned 10/27/2006

$366K
Total Medicaid Paid
28,234
Total Claims
25,667
Beneficiaries
32
Codes Billed
2018-01
First Month
2024-10
Last Month

Provider Details

Authorized OfficialCOLLAZO, NORMA (ADMINISTRATOR/M.T.)
NPI Enumeration Date10/27/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 5,156 $46K
2019 2,850 $26K
2020 3,176 $31K
2021 5,267 $78K
2022 5,570 $112K
2023 3,168 $38K
2024 3,047 $34K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 1,779 1,676 $75K
84443 Thyroid stimulating hormone (TSH) 3,337 3,088 $53K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,280 2,102 $53K
80061 Lipid panel 3,225 2,989 $42K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 5,165 4,647 $38K
80053 Comprehensive metabolic panel 3,592 3,291 $36K
81000 3,858 3,558 $12K
83036 Hemoglobin; glycosylated (A1C) 1,241 1,125 $12K
86328 566 534 $10K
82274 539 479 $8K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 247 200 $7K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 409 205 $5K
36415 Collection of venous blood by venipuncture 581 511 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 38 31 $1K
86701 155 146 $1K
84439 146 129 $1K
84436 203 193 $1K
86738 99 87 $1K
84479 157 148 $940.59
82043 142 114 $873.11
87088 98 91 $809.16
87086 Culture, bacterial; quantitative colony count, urine 70 65 $572.81
80048 Basic metabolic panel (calcium, ionized) 66 50 $562.00
87276 23 12 $280.35
87275 23 12 $280.35
86769 14 14 $266.00
84153 13 13 $240.60
86592 24 24 $95.42
85651 14 13 $47.23
82947 12 12 $46.05
87899 46 38 $35.58
87328 72 70 $0.00